Rbf Capital, LLC Oramed Pharmaceuticals Inc. Transaction History
Rbf Capital, LLC
- $2.16 Billion
- Q3 2025
A detailed history of Rbf Capital, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Rbf Capital, LLC holds 42,947 shares of ORMP stock, worth $102,213. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,947
Previous 42,947
-0.0%
Holding current value
$102,213
Previous $96,000
14.58%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ORMP
# of Institutions
53Shares Held
9.64MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN3.17MShares$7.54 Million7.66% of portfolio
-
Aquamarine Financial (Cayman) LTD George Town,1.97MShares$4.7 Million0.46% of portfolio
-
Murchinson Ltd. Toronto, A61.75MShares$4.17 Million0.77% of portfolio
-
Boothbay Fund Management, LLC New York, NY845KShares$2.01 Million0.04% of portfolio
-
Morgan Jess S & CO Inc366KShares$872,0342.07% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $92.4M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...